Rankings
▼
Calendar
ESPR FY 2000 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$481M
FY 2000 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2,000
Gross Profit
-$784,000
-39200.0% margin
Operating Income
-$28M
-1378600.0% margin
Net Income
-$28M
-1378800.0% margin
EPS (Diluted)
$-9.35
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$78M
Total Liabilities
$10M
Stockholders' Equity
$68M
Cash & Equivalents
$70M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2,000
$0
—
Gross Profit
-$784,000
-$683,223
-14.8%
Operating Income
-$28M
-$12M
-122.9%
Net Income
-$28M
-$11M
-158.4%
← FY 1999
All Quarters
FY 2001 →